ReportersNotebook — Over the Counter, 11/19/12
SUPPLIER NEWS — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine. Couched as the “next generation pseudoephedrine product,” Nexafed is a 30 mg PSE hydrochloride tablet that utilizes Acura’s trademarked Impede technology.
When using the “shake-and-bake” or “one-pot” method, the Impede technology yields approximately half as much methamphetamine as compared with a traditional PSE product — or 38% of the maximum possible pure methamphetamine out of each tablet — and consequently makes use of the cold medicine by “meth cooks” less profitable.
For other methods of baking meth out of PSE tablets, which require isolating the pseudoephedrine from the cold tablets, the Impede technology yields no usable pseudoephedrine.
“This is a high-recommendation category,” noted Acura CEO Bob Jones. “When the pharmacist gets behind a product like Nexafed … that message will translate into product sales.”
Eventually, Acura plans to file with the Drug Enforcement Agency for an exemption from the requirement that PSE products be sold behind the pharmacy counter. That would place a PSE product back on store shelves for the first time in seven years. Launching now will help Acura build a case of real-life positive outcomes, Jones told DSN.
Keeping health on track
ALAMEDA, Calif. — Abbott’s latest glucose meter, the FreeStyle Insulinx, is helping to bring blood-glucose monitoring up to speed with the latest in smartphone and tablet technology. The new meter features a touchscreen interface, automated logbook and is equipped with built-in FreeStyle Auto-Assist software that enables patients to track progress, analyze trends and easily display data for their healthcare providers.
Intimacy positioned more as health care
RH Labs just launched a line of intimacy health products endorsed by Laura Berman, a well-known sex and relationship expert who hosts the show “In The Bedroom” on the Oprah Winfrey Network. Berman collaborated on the design of every product in her line, the company noted.
It’s the kind of endorsement that will heighten the importance of intimacy health as part of an overall healthcare regimen.
Sales of intimacy enhancement devices were up 24.3% to $4.1 million over the 12 weeks ended Sept. 9, according to SymphonyIRI group data.
The article above is part of the DSN Category Review Series. For the complete Sexual Wellness Sell-Through Report, including extensive charts, data and more analysis, click here.